Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates

Catalent To Be Acquired by Novo Holdings

Skadden is representing contract drug manufacturer Catalent, Inc. in its $16.5 billion acquisition by Novo Holdings A/S.
BACK TO TOP